Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MNTA

Momenta Pharmaceuticals (MNTA) Stock Price, News & Analysis

Momenta Pharmaceuticals logo

About Momenta Pharmaceuticals Stock (NASDAQ:MNTA)

Advanced Chart

Key Stats

Today's Range
$52.48
$52.48
50-Day Range
$52.26
$52.49
52-Week Range
$12.21
$52.53
Volume
N/A
Average Volume
1.94 million shs
Market Capitalization
$6.25 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MNTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Momenta Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

MNTA Stock News Headlines

Johnson & Johnson Files for First FDA OK of Nipocalimab
Genoptix, Momenta Shares Headed for Gains
Missed the Run So Far? This Is Your Second Chance
According to history, the final stretch of the crypto cycle is here — and this short window is where fortunes are made. Inside The Crypto Code Workshop, two experts reveal how to get positioned early, lock in profits, and access their top altcoin picks before the crowd. All attendees receive $10 in free Bitcoin just for showing up.
Eastman Kodak, Rambus: After-Hours Trading
See More Headlines

MNTA Stock Analysis - Frequently Asked Questions

Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) issued its quarterly earnings results on Monday, August, 10th. The biotechnology company reported ($0.48) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.42) by $0.06. The biotechnology company earned $6.61 million during the quarter, compared to analysts' expectations of $5.84 million. Momenta Pharmaceuticals had a negative trailing twelve-month return on equity of 61.44% and a negative net margin of 757.61%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Momenta Pharmaceuticals investors own include NVIDIA (NVDA), Meta Platforms (META), Exelixis (EXEL), Gilead Sciences (GILD), Novavax (NVAX), Bristol Myers Squibb (BMY) and Shopify (SHOP).

Company Calendar

Last Earnings
8/10/2020
Today
7/18/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:MNTA
CIK
1235010
Fax
N/A
Employees
131
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$290.05 million
Net Margins
-757.61%
Pretax Margin
N/A
Return on Equity
-61.44%
Return on Assets
-45.28%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.38
Quick Ratio
6.38

Sales & Book Value

Annual Sales
$23.87 million
Price / Sales
261.69
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.59 per share
Price / Book
11.43

Miscellaneous

Outstanding Shares
119,029,000
Free Float
N/A
Market Cap
$6.25 billion
Optionable
Optionable
Beta
1.71
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:MNTA) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners